Decitabine Archives - Medical Conferences

Promising results for quizartinib, venetoclax, and decitabine in FLT3-ITD mutated AML

Presented By

Dr Musa Yilmaz, MD Anderson Cancer Center, TX, USA

Trial

Phase 1/2

Conference

ASH 2023

Type

Peer-reviewed article

7 February 2024 15:04

Presented By

Dr Musa Yilmaz, MD Anderson Cancer Center, TX, USA

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 11:46

Presented By

Dr Rachel Giles, Medicom

Conference

ASH 2021

4 January 2022 08:00

Presented By

Dr Abhishek Maiti, University of Texas MD Anderson Cancer Centre, USA

Trial

Phase 2

Conference

EHA 2020

Type

Peer-reviewed article

9 September 2020 13:18

Presented By

Dr Xiaowen Tang; Dr James Foran

Trial

Phase 2, ECOG-ACRIN E2906

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 13:16